Advancements in Macrophage-Targeted Drug Delivery for Effective Disease Management
Open Access
- 1 November 2023
- journal article
- review article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 18, 6915-6940
Abstract
Macrophages play a crucial role in tissue homeostasis and the innate immune system. They perform essential functions such as presenting antigens, regulating cytokines, and responding to inflammation. However, in diseases like cancer, cardiovascular disorders, and autoimmune conditions, macrophages undergo aberrant polarization, which disrupts tissue regulation and impairs their normal behavior. To address these challenges, there has been growing interest in developing customized targeted drug delivery systems specifically designed for macrophage-related functions in different anatomical locations. Nanomedicine, utilizing nanoscale drug systems, offers numerous advantages including improved stability, enhanced pharmacokinetics, controlled release kinetics, and precise temporal drug delivery. These advantages hold significant promise in achieving heightened therapeutic efficacy, specificity, and reduced side effects in drug delivery and treatment approaches. This review aims to explore the roles of macrophages in major diseases and present an overview of current strategies employed in targeted drug delivery to macrophages. Additionally, this article critically evaluates the design of macrophage-targeted delivery systems, highlighting limitations and discussing prospects in this rapidly evolving field. By assessing the strengths and weaknesses of existing approaches, we can identify areas for improvement and refinement in macrophage-targeted drug delivery.Keywords
This publication has 221 references indexed in Scilit:
- Adherence to Colorectal Cancer ScreeningArchives of internal medicine (1960), 2012
- Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectorsProceedings of the National Academy of Sciences, 2012
- Protective and pathogenic functions of macrophage subsetsNature Reviews Immunology, 2011
- Targeted drug delivery to tumors: Myths, reality and possibilityJournal of Controlled Release, 2011
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin LymphomaCell, 2010
- Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in miceNature Nanotechnology, 2009
- Signal regulatory protein alpha (SIRPα)/CD47 interaction and functionCurrent Opinion in Immunology, 2009
- Shape Induced Inhibition of Phagocytosis of Polymer ParticlesPharmaceutical Research, 2008
- Role of Particle Size in Phagocytosis of Polymeric MicrospheresPharmaceutical Research, 2008
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005